Medical oncologist Dr. Vinay Prasad’s short tenure as the FDA’s Director of the Center for Biologics Evaluation and Research has come to an end; ostensibly hired for his critical eye for Big Pharma-sponsored overblown trial results, he has been purportedly ousted for just that after a decision to pause a Duchenne muscular dystrophy drug made by Sarepta Therapeutics following three patient deaths. | Roubein, Washington Post 2025
